Copper iodide nanoparticles effective against 2009 pandemic H1N1 influenza virus

Feb 15, 2012

Copper-iodide nanoparticles have long-lasting antiviral activity against the 2009 pandemic H1N1 influenza virus, according to a paper in the February issue of the journal Applied and Environmental Microbiology.

The copper iodide generates which kill viruses by degrading viral proteins. The particles can be applied to products such as filters, face masks, kitchen cloths, counter tops, and other products where people might come into contact with virus particles, says first author Yoshie Fujimori of NBC Meshtec, Inc., Tokyo, Japan. This is the first demonstration of antiviral activity in copper-iodide nanoparticles.

"Copper-iodide has antiviral activity against other viruses, and antibacterial activity as well," says Fujimori. "We have already sold some products, such as face masks, disposable protective clothing, antiviral sheets and blankets, and bannisters."

Copper has long been known to have antibacterial activity, and several copper compounds had previously been found to have antiviral activity, against both and . But the colors of copper metal and copper oxide would have altered the appearance of any products to which they might be applied, while the white copper iodide nanoparticles would not have done so, says Fujimori.

Copper iodide nanoparticles are stable in air and water, which accounts for their long-lasting antiviral activity, whereas the commonly used alcohol hand-sanitizers are relatively ineffective against viruses.

The researchers showed that copper-iodide degrades , and they suspect that it does so by generating so-called reactive oxygen species, which are known to degrade proteins. A major advantage of this mechanism is that it would be extremely difficult for a virus to develop resistance to this mechanism, says Fujimori.

Explore further: Single-cell transfection tool enables added control for biological studies

More information: Y. Fujimori, T. Sato, T. Hayata, T. Nagao, M. Nakayama, T. Nakayama, R. Sugamata, and K. Suzuki, 2012. Novel antiviral characteristics of nanosized copper(I) iodide particles showing inactivation activity against 2009 pandemic H1N1 influenza virus. Appl. Environ. Microbiol. 78:951-955.

Provided by American Society for Microbiology

4.3 /5 (3 votes)
add to favorites email to friend print save as pdf

Related Stories

High iron, copper levels block brain-cell DNA repair

May 20, 2011

No one knows the cause of most cases of Alzheimer's, Parkinson's and other neurodegenerative disorders. But researchers have found that certain factors are consistently associated with these debilitating conditions. One is ...

Dietary copper may ease heart disease

Mar 05, 2007

Including more copper in your everyday diet could be good for your heart, according to scientists at the University of Louisville Medical Center and the USDA Human Nutrition Research Center. Their studies show that giving ...

Recommended for you

Radioactive nanoparticles target cancer cells

May 21, 2013

Cancers of all types become most deadly when they metastasize and spread tumors throughout the body. Once cancer has reached this stage, it becomes very difficult for doctors to locate and treat the numerous tumors that can ...

How gold nanoparticles can help fight ovarian cancer

May 21, 2013

Positively charged gold nanoparticles are usually toxic to cells, but cancer cells somehow manage to avoid nanoparticle toxicity. Mayo Clinic researchers found out why, and determined how to make the nanoparticles effective ...

User comments : 0

More news stories

Scientists develop cheaper, more efficient fuel cells

(Phys.org) —Using the Canadian Light Source (CLS) synchrotron, researchers have discovered a way to create cheaper fuel cells by dividing normally expensive platinum metal into nanoparticles (or even single ...

Source of life running out: water scientists

The majority of people on Earth people will face severe water shortages within a generation or two if pollution and waste continues unabated, scientists warned at a conference in Bonn Friday.